Retosiban

N/A

Report date: 2026/02/11 20:01:36
NME

Base Information

Drug NameRetosiban
Drug Alias Nameretosibanum瑞托西班GSK-221149GSK-221149A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOxytocin receptor antagonists
TargetsOxytocin receptor
Therapy Area/IndicationsPremature BirthObstetric Labor, Premature
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumBulgariaCanada +[19] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsPremature BirthObstetric Labor, Premature

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG